18 results
6-K
CNTB
Connect Biopharma Holdings Ltd
30 Dec 22
Connect Biopharma Provides Business and Clinical Development Program Update
8:00am
that it had determined, in light of the current macroeconomic climate and challenging funding environment, to commence its Global Phase 3 program
6-K
EX-99.1
CNTB
Connect Biopharma Holdings Ltd
30 Dec 22
Connect Biopharma Provides Business and Clinical Development Program Update
8:00am
environment, we feel that it is necessary and financially prudent to commence our Global Phase 3 program for CBP-201 in moderate-to-severe AD after we have
F-3/A
CNTB
Connect Biopharma Holdings Ltd
17 Jun 22
Shelf registration (foreign) (amended)
5:19pm
-based companies could adversely affect our business and results of operations. If the business environment in the PRC deteriorates from … business and results of operations. If the business environment in the PRC deteriorates from the perspective of domestic or international investment, the PRC
F-3/A
t6f mos03
20 May 22
Shelf registration (foreign) (amended)
6:54pm
F-3
88vphyb0h01n
15 Apr 22
Shelf registration (foreign)
5:27pm
F-3
EX-1.2
0cr5mu8
15 Apr 22
Shelf registration (foreign)
5:27pm
20-F
u592f242hc qlkvw3v7i
31 Mar 22
Annual report (foreign)
4:33pm
424B4
9x892 r5erab3dl
19 Mar 21
Prospectus supplement with pricing info
4:49pm
F-1/A
d8c q652mp
18 Mar 21
Registration statement (foreign) (amended)
6:15am
F-1/A
i3bfwxp1bwole
12 Mar 21
Registration statement (foreign) (amended)
5:02pm
F-1/A
EX-99.1
0xj8rfx6385ue2rp55zo
12 Mar 21
Registration statement (foreign) (amended)
5:02pm
F-1/A
EX-1.1
7axsuaj
12 Mar 21
Registration statement (foreign) (amended)
5:02pm
F-1
EX-10.13
2gq7lzt z968sorc3r
26 Feb 21
Registration statement (foreign)
4:56pm
F-1
apa8u4xjxlo
26 Feb 21
Registration statement (foreign)
4:56pm
DRS/A
k7stdib
26 Jan 21
Draft registration statement (amended)
12:00am
DRS
zl70345 rskudx
17 Dec 20
Draft registration statement
12:00am
- Prev
- 1
- Next